Drug factory · FDA FEI 3002806718
Wavelength Enterprises Ltd
Eco-Industrial Park, Neot-Hovav, Israel
No problems found at FDA's last inspection, Dec 14, 2022.
No Action Indicated: inspectors found no objectionable conditions.
4 drug inspections on record since 2010: 2 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Granisetron | Makes the active ingredient | Heron Therapeutics, Inc. | 47426-101 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 14, 2022 | No problems found | Drug Quality Assurance | — |
| Jul 12, 2018 | No problems found | Drug Quality Assurance | — |
| Mar 14, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 4, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.